Rikhav Securitie (544340)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter sales of ₹380 Cr against market cap of ₹166 Cr suggests substantial business turnover relative to the equity value, if the run-rate holds.
• ROCE of 16.68% indicates respectable capital efficiency on the capital employed.
• Latest quarter net profit of ₹18 Cr, though thin, proves the company can generate positive earnings.
• Sales growth of 309.12% shows the firm is winning more broking and allied business in the current market environment.

Concerns

• Reported P/E of 0.00 gives no reliable trailing earnings base for valuation.
• Profit growth of -64.95% despite sales growth of 309.12% signals severe margin compression or one-off costs.
• Piotroski F-score of 4/9 points to weak financial fundamentals.
• Missing book value, debt/equity, promoter holding, and 52-week range means I cannot assess downside risk properly.

AI Analysis

Rikhav Securitie tempts me with a classic Graham paradox: a ₹166 Cr market cap against a latest-quarter sales figure of ₹380 Cr. But in stockbroking, revenue is not profit, and the income statement is shouting a warning. While sales grew 309%, profit shrank nearly 65%. The reported P/E of 0.00 tells me the trailing earnings stream is either missing or meaningless; the latest quarter's ₹18 Cr net profit on ₹380 Cr sales is only a 4.7% margin. Broking is a cyclical, competitive, price-taking business. There is no brand moat, no pricing power, and customers leave when the next discount platform arrives. A Piotroski F-score of 4/9 reinforces my caution: the fundamentals are mediocre, not robust. ROCE of 16.68% is respectable, but without book value, debt-to-equity, promoter holding, or a 52-week range, I cannot compute a margin of safety. Graham would demand: first, protect the downside. A 309% sales jump in a rising market may simply mirror trading volumes, not durable earning power. If the quarterly profit of ₹18 Cr were to be sustained annualised, the stock would appear absurdly cheap, but I refuse to capitalise a single quarter in a low-moat cyclical. I need years of data, not one explosive quarter. For now, this is a show-me story. I will watch whether profit growth turns positive, margins widen, and the balance sheet gives me real numbers. Until then, curiosity, not conviction.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer